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ABSTRACT
Background: Aspiration thrombectomy is recommended as an 
adjunctive method in patients undergoing primary percutane-
ous coronary intervention (PCI), however, thrombus aspiration 
failure is relatively frequent. The objective of this study was 
to evaluate the rate and identify predictors of failed thrombus 
aspiration in a contemporaneous series of patients. Methods: 
Prospective cohort study including consecutive patients with 
acute ST-segment elevation myocardial infarction undergoing 
primary PCI with thrombus aspiration from December 2009 
to December 2011. Aspiration thrombectomy was performed 
at the operator’s discretion and success was defined as ef-
fective thrombus aspiration by a dedicated catheter with the 
achievement of a final TIMI flow > 0. Results: 1,055 primary 
PCIs were performed and aspiration thrombectomy was used 
in 37% of cases with a success rate of 70%. Aspiration 
thrombectomy success was observed in 254 patients whereas 
failure was observed in 107 patients. Aspiration thrombectomy 
failure was associated with age, hypertension, diabetes mel-
litus, dyslipidemia, previous PCI, TIMI risk score, Killip IV, 
leukocyte count, serum fibrinogen, target vessel reference 
diameter and preprocedural TIMI 3 flow. Patients with failed 
thrombus aspiration had a trend towards higher mortality (11.6% 
vs. 5.9%; P = 0.09). Conclusions: Aspiration thrombectomy 
failure during primary PCI was observed in 30% of the cases 
and was associated with a trend towards higher mortality. The 
identification of clinical, laboratory and angiographic predic-
tors may help improve these devices and the technique and 
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RESUMO
Preditores de Insucesso de Tromboaspiração em 
Pacientes Submetidos à Intervenção Coronária 
Percutânea Primária
Introdução: A tromboaspiração é recomendada como método 
adjunto à intervenção coronária percutânea (ICP) primária, mas 
o insucesso em recuperar trombos é relativamente frequente. 
O objetivo deste estudo foi avaliar as taxas de insucesso de 
tromboaspiração e identificar seus preditores, em uma série 
contemporânea de pacientes. Métodos: Estudo de coorte 
prospectivo que incluiu pacientes consecutivos atendidos com 
infarto agudo do miocárdio com elevação do segmento ST e 
submetidos à ICP primária com tromboaspiração no período de 
dezembro de 2009 a dezembro de 2011. Os procedimentos de 
tromboaspiração foram realizados por decisão do operador, e 
o sucesso foi definido como aspiração efetiva de trombo pelo 
cateter dedicado, com recuperação do fluxo coronário (fluxo 
TIMI > 0). Resultados: Foram realizadas 1.055 ICPs primárias, 
sendo que a tromboaspiração foi utilizada em 37% dos ca-
sos, com taxa de sucesso de 70%. Foram identificados 254 
pacientes com sucesso e 107 com insucesso da tromboaspi-
ração. Insucesso de tromboaspiração foi associado a: idade, 
hipertensão, diabetes mellitus, dislipidemia, ICP prévia, escore 
de risco TIMI, Killip IV, contagem de leucócitos, fibrinogênio 
sérico, diâmetro de referência do vaso-alvo e TIMI 3 pré-
procedimento. Pacientes com insucesso da tromboaspiração 
apresentaram tendência a maior mortalidade (11,6% vs. 5,9%; 
P = 0,09). Conclusões: Insucesso de tromboaspiração durante 
ICP primária ocorreu em 30% dos casos e esteve associado 
a tendência de maior mortalidade. A identificação de predi-
tores clínicos, laboratoriais e angiográficos pode auxiliar no 
aprimoramento desses dispositivos e em sua técnica, além 
da escolha de pacientes mais adequados para seu emprego. 
DESCRITORES: Infarto do miocárdio. Intervenção coronária 
percutânea. Trombectomia. Fatores de risco.
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The inclusion criterion was AMI with indication 
of primary PCI by the attending physician. AMI was 
defined as a typical chest pain at rest associated with 
persistent ST-segment elevation of at least 1 mm in two 
contiguous leads in the frontal plane, or 2 mm in the 
horizontal plane, or the presence of a typical chest 
pain at rest in patients with new (or presumably new) 
left bundle branch block. The exclusion criteria were 
chest pain lasting >  12 hours, age <  18 years, or no 
written consent to participate in the study.
Clinical and angiographic characteristics
All patients were evaluated immediately after the 
hospital admission, and their clinical, angiographic, 
and laboratory data were recorded and stored in a 
dedicated database. The patients received a daily visit 
from one of the researchers to assess the occurrence 
of in-hospital outcomes.
The angiographic evaluations were performed 
in at least two projections by experienced surgeons, 
using a previously validated digital electronic system 
(Axiom Artis; Siemens – Munich, Germany) and intra-
coronary nitroglycerin was routinely administered in 
doses of 100 to 200 mcg prior to the measurements. 
The diameter of the target vessel was defined as the 
average of luminal diameters proximal and distal to 
the lesion, and the stenosis severity was measured in 
two orthogonal projections. The length of the lesion 
was measured “shoulder to shoulder”, and long le-
sions were considered as singular in the presence of 
a normal arterial segment <  10 mm between them. 
The coronary flow was evaluated before and after the 
procedures, and described according to TIMI criteria.3 
The myocardial perfusion was evaluated by myocardial 
blush, as previously described.4
Primary PCI procedures
The IC/FUC is a tertiary interventional cardiology 
center that performs approximately 2,500 coronary in-
terventions per year. Thrombus aspiration was performed 
with one of three manual suction catheters available: 
Export (Medtronic Vascular Inc. – Santa Rosa, USA), 
Diver CE (Invatec – Brescia, Italy), or Pronto (Vascular 
Solutions – Minneapolis, USA). The aspects related to 
the procedure, such as access route, administration of 
glycoprotein IIb/IIIa inhibitors and number of implanted 
stents, as well as the decision for conducting the throm-
bus aspiration, were left to the surgeons’ discretion. The 
thrombus aspiration was performed before the balloon 
dilation (as described in TAPAS study),10 with several 
passages, if necessary. The intra-aortic balloon was used 
only in patients with cardiogenic shock.
The drugs used in the initial care and the indication 
for primary percutaneous coronary intervention were 
left to the discretion of the care team, according to the 
clinical routine. All patients received a loading dose 
C ardiovascular diseases remain the main cause of death in Brazil.1 Acute myocardial infarction (AMI) is the most severe manifestation. Mechanical re-
canalization treatment is the best choice if this procedure 
is available in the first 12 hours, thereby decreasing the 
mortality, when compared with fibrinolytics.2
The presence of an intracoronary thrombus is 
associated to worse coronary flow and myocardial 
perfusion, which can be quantified by Thrombolysis in 
Myocardial Infarction (TIMI)3 classification and by the 
degree of myocardial blush,4 respectively. Moreover, 
the clinical outcome is worse in this subgroup, both in 
the in-hospital phase and in the late phase.5-7 Coronary 
thrombus is also a predictor of late thrombosis.8
Coronary thrombus is present in most manifestations 
of acute coronary syndrome, with high prevalence in 
patients with AMI and ST-segment elevation. To reduce 
the thrombus burden by pharmacologic means, throm-
bolytic, antiplatelet, anticoagulant agents, and glycopro-
tein IIb/IIIa inhibitors are used. Devices for mechanical 
removal are advantageous versus antithrombotic agents, 
because these procedures do not increase the risk of 
bleeding. Aspirators may be electronic or manual, and 
the latter type is more popular, for its simplicity and 
costs. Despite the increasing use of pharmacological 
and mechanical therapy, distal coronary embolization 
may occur in 6%-15% of cases of AMI,9 causing de-
creased tissue perfusion, with consequent increase in 
AMI extent and mortality.7,8
There are several clinical trials evaluating the ef-
ficacy of devices for thrombus aspiration in mechanical 
recanalization procedures for AMI. A meta-analysis of 
these studies showed an improvement of the surrogate 
outcomes related to myocardial perfusion. In addition, 
some studies have suggested improvement of perfusion, 
myocardial blush, ST-segment resolution, and mortality,10-12 
and the effectiveness in the implementation of thrombus 
aspiration depends of clinical and angiographic factors.13
The aim of this study was to evaluate failure rates 
of thrombus aspiration, with identification of their pre-
dictors in a contemporary cohort of patients undergoing 
primary percutaneous coronary intervention (PCI), and 




This was a prospective cohort study that included 
all AMI patients undergoing primary PCI in Instituto de 
Cardiologia da Fundação Universitária de Cardiologia 
do Rio Grande do Sul (IC/FUC) in the period from 
December 2009 to December 2011. The project was 
approved by the ethics committee, and all patients 
received information about the study and signed an 
informed consent.
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(300 mg) of acetylsalicylic acid (ASA) and clopidogrel 
(300 to 600 mg). After the coronary angiography, un-
fractionated heparin was administered at a dose of 60 
to 100 U/kg. Primary PCI was performed as described 
in the guidelines.14
Outcomes and follow-up
All patients were followed during their hospi-
talization period, and the occurrence of events one 
month after the index procedure was assessed by 
telephone contact from one of the researchers. Major 
adverse cardiovascular events (MACE) were defined as 
the combination of death from all causes, recurrent 
AMI, or stroke. Recurrent AMI was defined as a chest 
pain with new elevation of markers of myocardial 
injury, associated to a new ST-segment elevation or 
Q wave. Stroke was defined as a focal neurological 
deficit, beginning suddenly, and irreversible in the first 
24 hours.
Statistical analysis
The results were presented as mean and standard 
deviation or absolute number and percentage. Variables 
with asymmetric distribution were presented as me-
dian and interquartile range. For comparisons among 
categorical variables, the chi-squared or Fisher’s exact 
test were used. For comparisons among continuous 
variables, Student’s t-test was used. The Mann-Whitney 
test was used for variables with asymmetric distribution. 
A two-tailed P-value of <  0.05 was considered signifi-
cant. Data were collected using an ACCESS database, 
and the statistical analysis was performed using SPSS 
version 17.0 for Windows (SPSS Inc. – Chicago, Illinois, 
United States).
The authors are responsible for the design and 
conduction of the study, its analysis, writing and editing 
of the manuscript, and approval of the final content. 
Absolutely no external funding was used to support 
this work.
RESULTS
During the study period, 1,055 patients diagnosed 
with AMI underwent primary PCI; of these, 986 cases 
had < 12 hours of symptoms. Manual thrombus aspiration 
was used in 37% of cases, with 70% success. Thus, the 
study identified 254 patients with successful thrombus 
aspiration and 107 patients with failure, whose clinical 
characteristics are presented in Table 1. Thrombus aspi-
ration failure was associated with older age, systemic 
hypertension, diabetes mellitus (DM), dyslipidemia, 
previous AMI, primary PCI, cardiac insufficiency, and 
TIMI risk score (P <  0.05 for all associations).
Regarding angiographic and laboratory character-
istics, TIMI 3 flow pre-primary PCI (P = 0.08), smaller 
reference diameter of the target vessel, lower platelet 
and leukocyte count (P = 0.09), and increased serum 
fibrinogen were associated with thrombus aspiration 
failure. Regarding the drugs used in the first 24 hours of 
care, thrombus aspiration failure presented a tendency 
for association with decreased use of glycoprotein 
IIb/IIIa inhibitors (Tables 2-4).
Patients with thrombus aspiration failure showed a 
higher percentage of MACE, although without statisti-
cally significant difference (9.4% vs. 13.2%; P = 0.35) 
and with a trend to higher mortality (5.9% vs. 11.6%; 
P = 0.09), as shown in Figure 1.
DISCUSSION
Previous studies have demonstrated the benefit of 
thrombus aspiration in patients undergoing primary PCI 
for AMI.10-12 However, the clinical and angiographic 
predictors of failure of thrombus aspiration were not 
reported in these studies.
Vink et al,13 in a single-centre study, demonstrated 
that calcified lesions, marked tortuosity, and bifurcation 
lesions were independent predictors of failure of the 
thrombus aspiration catheter to overcome the target 
lesion. Age > 60 years and left circumflex artery were 
independent predictors of failure of thrombus aspira-
tion. This was the first nationwide trial evaluating 








(n = 107) P
Age, years 58.1 ± 11.6 61.5 ± 11.3 < 0.01
Male, n (%) 180 (71) 66 (62) 0.11
Smoking, n (%) 122 (48) 42 (39) 0.22
Hypertension, n (%) 142 (56) 72 (67) 0.04
Diabetes, n (%) 43 (17) 29 (27) 0.03
Dyslipidemia, n (%) 79 (31) 45 (42) 0.05
CAD FH, n (%) 76 (30) 33 (31) 0.93
Anterior AMI n (%) 199 (47) 46 (43) 0.62
Killip class IV, n (%) 10 (4) 9 (8) 0.42
Prior MI, n (%) 33 (13) 25 (23) 0.02
CHF, n (%) 8 (3) 9 (8) 0.04
Previous CABG, n (%) 3 (1) 4 (4) 0.16
Prior PCI, n (%) 33 (13) 26 (24) 0.01
TIMI score 3.3 ± 2.3 4.1 ± 2.6 < 0.01
CAD FH = positive family history of coronary artery disease; 
AMI = acute myocardial infarction; CHF = congestive 
heart failure; CABG = myocardial revascularization; PCI = 
percutaneous coronary intervention; TIMI = Thrombolysis in 
Myocardial Infarction.
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(n = 107) P
Access route, n (%) 0.89
Femoral 203 (80) 88 (82)
Radial 51 (20) 19 (18)
Extent of CAD, n (%) 0.16
One vessel 135 (53) 50 (47)
Three vessels 36 (14) 22 (21)
6 F sheat, n (%) 208 (82) 95 (89) 0.10
Injured vessels, n (%) 0.16
LAD 121 (48) 44 (41)
LCx 28 (11) 11 (10)
RCA 102 (40) 50 (47)
LMCA 1 (0.4) 0
Bridge 2 (0.8) 2 (1.7)
Bifurcation, n (%) 56 (22) 17 (16) 0.14
Thrombus, n (%) 249 (98) 92 (86) < 0.01
Calcium, n (%) 36 (14) 20 (19) 0.23
TIMI flow pre, n (%) 0.08
0 218 (86) 87 (81)
3 15 (6) 13 (12)
Blush pre, n (%) < 0.01
0 239 (94) 93 (87)
3 8 (3) 7 (7)
TIMI flow post, n (%) 0.24
0 5 (2) 2 (2)
3 226 (89) 91 (85)
Blush post, n (%) 0.85
0 43 (17) 18 (17)
3 152 (60) 62 (58)
Stenting, n (%) 239 (94) 92 (86) < 0.01
Post-dilation, n (%) 84 (33) 32 (30) 0.58
Pre-stenosis, % 99.2 ± 3.04 99.1 ± 2.55 0.58
Post-stenosis after, % 2.17 ± 12.6 5.2 ± 19.2 0.12
Extension, mm 18.8 ± 9.8 19.3 ± 1 0.64
Reference diameter, mm 3.34 ± 0.49 3.2 ± 0.41 0.13
Final diameter, mm 3.58 ± 0.53 3.44 ± 0.48 0.02
Complications, n (%) 0.63
No complications 213 (84) 86 (80)
No reflow 15 (6) 2 (2)
CAD = coronary artery disease; LADA = left anterior descendent 
artery; LCx = left circumflex artery; RCA = right coronary artery; 
LMCA = left main coronary artery; TIMI = Thrombolysis in 
Myocardial Infarction.
TABLE 3 





(n = 107) P
ASA, n (%) 249 (98) 104 (97) > 0.99
Beta-blocker, n (%) 178 (70) 81 (76) 0.29
ACEI, n (%) 178 (70) 78 (73) 0.62
Nitrite, n (%) 61 (24) 31 (29) 0.43
Clopidogrel mg, n (%) 0.11
300 43 (17) 11 (10)
600 211 (83) 96 (90)
Glycoprotein IIb/IIIa 
inhibitor, n (%)
130 (51) 43 (40) 0.06
Heparin, n (%) 170 (67) 76 (71) 0.42








(n = 107) P
Cholesterol, mg/dL 205.7 ± 49.0 195.5 ± 42.2 0.07
HDL cholesterol, mg/dL 39.9 ± 11.3 42.4 ± 13.1 0.09
Triglycerides, mg/dL 156.3 ± 156.0 150.1 ± 115.0 0.72
Creatinine, mg/dL 0.99 ± 0.34 1.00 ± 0.41 0.91
Blood Glucose mg/dL 161.2 ± 57.8 175.1 ± 80.0 0.12
Hematocrit, % 40.9 ± 4.2 40.4 ± 4.5 0.30
Hemoglobin, g/dL 13.8 ± 1.5 13.5 ± 1.6 0.17





Leukocytes, mm3 13,963 ± 4,990 12,620 ± 4,772 0.01
HbA1c, % 5.5 ± 0.2 6.4 ± 1.2 0.15
CK, U/L 474.5 ± 748.7 423.1 ± 639.0 0.31
CK-MB, ng/ml 40.4 ± 67.7 30.6 ± 43.0 0.54
Troponin U.S., ng/dL 2,077 ± 3,283 1,451 ± 924 0.15
CRP, mg/dL 1.1 ± 2.1 1.5 ± 3.8 0.20
Fibrinogen, mg/dL 221.6 ± 70.9 253.7 ± 90.4 < 0.01
HDL = high-density lipoprotein; CK = creatinephosphokinase; 
U.S. = ultrasensitive; CRP = C-reactive protein.
Clinical characteristics of major morbidity, such 
as presence of hypertension, diabetes, dyslipidemia, 
and older age, may be related to a greater extent of 
coronary atherosclerosis, with greater difficulty in the 
thrombus aspiration. The severity and the extent of the 
atherosclerotic plate may hinder the progression of the 
suction catheter.
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TIMI 3 pre-coronary flow was also predictor of 
failure, an association that may have been influenced 
by bias, thanks to the minor insistence on thrombus 
aspiration in patients who already had the desired 
coronary flow, or who exhibited less thrombus burden. 
A significant difference in final TIMI flow outcomes was 
not observed between the two groups with and without 
successful thrombus aspiration.
In cases of AMI, the content of platelets and fi-
brin in the thrombus is highly dependent on ischemic 
time. A longer ischemic time is associated with higher 
content of fibrin and lower content of platelets in the 
occlusive thrombus.15 It is possible that the group with 
unsuccessful thrombus aspiration, which showed smaller 
number of circulating platelets and a higher level 
of serum fibrinogen, would present longer ischemic 
times and more organized thrombi, which hampered 
the aspiration.
This study also demonstrated that there was a ten-
dency for higher mortality and lower use of glycoprotein 
IIb/IIIa inhibitors in cases of thrombus aspiration failure.
Limitations of the study
The potential limitations of this study include its 
observational design, limited to patients who under-
went manual thrombus aspiration at the discretion of 
the surgeon’s analysis. For convenience, this selection 
possibly excluded cases of greater anatomical com-
plexity, which could provide more information about 
the predictors of failure. The relatively small sample 
size should also be highlighted, making it impossible 
to conduct multivariate analysis in order to identify 
independent predictors of failure. However, the inclu-
sion of patients for a longer period of time could not 
represent the contemporary treatment of AMI, of which 
manual thrombus aspiration is inserted part; rather, the 
authors opted for the analysis of patients treated over 
a two-year period. In addition, an analysis of outcome 
in the medium and long term was not presented; the 
follow-up of these patients was not greater than 30 
days from the index event.
When analyzing the angiographic variables, the 
presence of a visible thrombus was described, but the 
classification of the thrombotic burden was not ap-
plied, which could help to differentiate the degree of 
thrombus burden that is associated with failure in the 
thrombus aspiration technique.8,16
Regarding the comparison of the present results with 
the literature, the lack of standardisation of the outcomes 
of thrombus aspiration success and failure suggests 
that caution should be exercised in the analysis of the 
studies published to date, and that a standardization of 
outcomes would assist in future comparison of results.
CONCLUSIONS
Failure of thrombus aspiration during primary per-
cutaneous coronary intervention occurred in 30% of 
cases and was associated with a trend toward higher 
mortality. The identification of clinical, angiographic, 
and laboratory predictors can help to improve these 
devices and the pertinent technique, in addition to 
selecting the most appropriate patients for their use. The 
analysis of a larger number of patients with a longer 
follow-up may be needed, to define the prognostic role 
of thrombus aspiration failure.
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